Your browser doesn't support javascript.
loading
Thrombosis from a prothrombin mutation conveying antithrombin resistance.
Miyawaki, Yuhri; Suzuki, Atsuo; Fujita, Junko; Maki, Asuka; Okuyama, Eriko; Murata, Moe; Takagi, Akira; Murate, Takashi; Kunishima, Shinji; Sakai, Michio; Okamoto, Kohji; Matsushita, Tadashi; Naoe, Tomoki; Saito, Hidehiko; Kojima, Tetsuhito.
Affiliation
  • Miyawaki Y; Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
N Engl J Med ; 366(25): 2390-6, 2012 Jun 21.
Article in En | MEDLINE | ID: mdl-22716977
ABSTRACT
We identified a novel mechanism of hereditary thrombosis associated with antithrombin resistance, with a substitution of arginine for leucine at position 596 (p.Arg596Leu) in the gene encoding prothrombin (called prothrombin Yukuhashi). The mutant prothrombin had moderately lower activity than wild-type prothrombin in clotting assays, but the formation of thrombin-antithrombin complex was substantially impaired. A thrombin-generation assay revealed that the peak activity of the mutant prothrombin was fairly low, but its inactivation was extremely slow in reconstituted plasma. The Leu596 substitution caused a gain-of-function mutation in the prothrombin gene, resulting in resistance to antithrombin and susceptibility to thrombosis.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Prothrombin / Point Mutation / Venous Thrombosis / Antithrombin Proteins Type of study: Prognostic_studies Limits: Adolescent / Female / Humans / Male Language: En Year: 2012 Type: Article

Full text: 1 Database: MEDLINE Main subject: Prothrombin / Point Mutation / Venous Thrombosis / Antithrombin Proteins Type of study: Prognostic_studies Limits: Adolescent / Female / Humans / Male Language: En Year: 2012 Type: Article